雜志介紹

Transboundary And Emerging Diseases雜志介紹

《Transboundary And Emerging Diseases》是一本以English為主的未開放獲取國際優秀期刊，中文名稱跨界和新發疾病，本刊主要出版、報道農林科學-VETERINARY SCIENCES領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3.5，最新CiteScore 指數為8.9。

本刊近期中國學者發表的論文主要有：

• Isolation and Characterization of Porcine Sapelovirus from the PDCoV-Positive Sample and Its Molecular Epidemiology in Henan Province, China

  Author: Zhang, Yunfei; Li, Qianqian; Si, Lulu; Gao, Junlong; Yuan, Jin; Xia, Lu; Hu, Hui

• Isolation, Identification, Sequence Analysis, and Pathogenicity of a CIAV Strain from Aegypius monachus

  Author: Yin, Mingrong; Tang, Zhipeng; Hu, Xiaoran; Li, Yuyan; Guo, Longzong; Sun, Xiaolong; Chang, Shuang; Zhao, Peng; Wang, Yixin

• Potential Zoonotic Transmission of Giardia duodenalis between Children and Calves in Bangladesh

  Author: Li, Junqiang; Karim, Md Robiul; Siddiki, S. H. M. Faruk; Chen, Yuancai; Qin, Ziyang; Rume, Farzana Islam; Zhang, Longxian

• Emerging Highly Pathogenic Avian Influenza (H5N8) Virus in Podiceps nigricollis in Northwest China in 2021

  Author: He, Zhen; Jin, Tiezhi; Wu, Weikang; Zhao, Zhe; Lu, Zhenhua; Song, Shuxuan; Liu, Kun; Shao, Zhongjun

英文介紹

Transboundary And Emerging Diseases雜志英文介紹

Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):

Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.

Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.

Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.

Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).

Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.